ASAM Guideline Topic Nomination Form

The American Society of Addiction Medicine (ASAM) is accepting nominations for clinical practice guideline topics from our members, stakeholders, and the general public.

ASAM clinical practice guidelines address prevention, screening, diagnosis, and treatment of conditions within the scope of addiction medicine and are targeted primarily towards clinicians and physicians. This submission form will prompt the nominator to provide information on the relevance of the proposed topic, availability of evidence to support guideline development, and the likelihood that the guideline will improve addiction treatment. Nominated topics will be reviewed on an annual basis by the Clinical Practice Guideline Methodology and Oversight Subcommittee (CPG-MOS) and the Quality Improvement Council (QIC).

If you are interested in nominating a guideline topic, please complete the form below.

Question Title

* 1. Name

Question Title

* 2. Credentials

Question Title

* 3. Affiliation

Question Title

* 4. Email Address

Question Title

* 5. Are you an ASAM member?

Yes

Question Title

* 6. If you are not an ASAM member, please indicate the name of your ASAM member partner. (Optional)

Question Title

* 7. What is the general guideline topic you are proposing in 5 words or less? Please note that ASAM clinical practice guidelines should address prevention, screening, diagnosis, and treatment of conditions within the scope of addiction medicine.

Question Title

* 8. Please give a brief overview of the proposed topic. For example, what key questions will the guideline on this topic answer? Suggested word limit: 250 words or less.

Question Title

* 9. Would your topic be better addressed through ASAM's policy or advocacy efforts? (If yes, please reach out to Corey Barton at cbarton@asam.org.)

Yes

Question Title

* 10. Why is this topic important for consideration as a clinical practice guideline and how will it improve addiction treatment? For example, what is the prevalence of the condition and its effect on morbidity and mortality?

Question Title

* 11. What is the need for this guideline? (e.g., evidence of quality gap/lack of consensus in the field, a clinical practice guideline does not already exist on the topic, etc.)

Question Title

* 12. What evidence is available to support this topic? Please list up to five key primary or grey literature resources in the form of URLs or reference citations.

Question Title

* 13. Please list any other guidelines developed on your specific topic suggestions within the past 5 years.

Question Title

* 14. Is there any additional information you wish to share?